Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia
- 7 July 2015
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 112 (31), 9722-9727
- https://doi.org/10.1073/pnas.1423827112
Abstract
Benign prostatic hyperplasia (BPH) is characterized by an enlargement of the prostate, causing lower urinary tract symptoms in elderly men worldwide. However, the molecular mechanism underlying the pathogenesis of BPH is unclear. Anoctamin1 (ANO1) encodes a Ca2+-activated chloride channel (CaCC) that mediates various physiological functions. Here, we demonstrate that it is essential for testosterone-induced BPH. ANO1 was highly amplified in dihydrotestosterone (DHT)-treated prostate epithelial cells, whereas the selective knockdown of ANO1 inhibited DHT-induced cell proliferation. Three androgen-response elements were found in the ANO1 promoter region, which is relevant for the DHT-dependent induction of ANO1. Administration of the ANO1 blocker or Ano1 small interfering RNA, inhibited prostate enlargement and reduced histological abnormalities in vivo. We therefore concluded that ANO1 is essential for the development of prostate hyperplasia and is a potential target for the treatment of BPH.Funding Information
- National Research Foundation of Korea (NRF-2013R1A1A2063015)
- National Research Foundation of Korea (NRF-2014R1A2A1A10052265)
This publication has 43 references indexed in Scilit:
- Anoctamin 1 (Tmem16A) Ca 2 + -activated chloride channel stoichiometrically interacts with an ezrin–radixin–moesin networkProceedings of the National Academy of Sciences of the United States of America, 2012
- Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROSAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Ano1 as a regulator of proliferationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention TrialAmerican Journal of Epidemiology, 2011
- TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial CellsJournal of Biological Chemistry, 2011
- Inhibition of Ca 2+ ‐activated Cl − channels by gallotannins as a possible molecular basis for health benefits of red wine and green teaThe FASEB Journal, 2010
- Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal musclesJournal Of Physiology-London, 2009
- UA62784, a novel inhibitor of centromere protein E kinesin-like proteinMolecular Cancer Therapeutics, 2009
- Expression Cloning of TMEM16A as a Calcium-Activated Chloride Channel SubunitCell, 2008